Understanding financial vulnerability in older adults with Alzheimer's disease
Official title: Mid-Career Development and Mentoring on Financial Vulnerability and Alzheimer's Disease
Funded at University of Southern California · NIH-11013893 · Data updated 2026-11-12
This study is looking at why older adults with Alzheimer's and related conditions might be more at risk of being taken advantage of financially, and it aims to understand how their thinking and behavior affect their money decisions.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Southern California NIH-funded |
| Lab location | 1 site (Los Angeles, UNITED STATES) |
| Project start | April 1, 2023 |
| Project end | January 31, 2028 |
| Funding year | 2025 |
| Award (this year) | $199,219 |
| NIH project number | 5K24AG081325-03 |
| Project ID | NIH-11013893 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are older adults aged 65 and above, especially those diagnosed with Alzheimer's Disease, Related Dementias, or Mild Cognitive Impairment.
✕Less likely to help
Patients who are younger than 65 or do not have cognitive impairments related to Alzheimer's Disease may not benefit from this research.
What this research studies
This research investigates the factors that make older adults, particularly those with Alzheimer's Disease and Related Dementias (ADRD), more susceptible to financial exploitation. It aims to explore behavioral, contextual, and neurobiological influences on financial decision-making in this population. By collaborating with the Rush Alzheimer’s Disease Center, the study will utilize various datasets and research mentors to gain insights into cognitive decline and its impact on financial vulnerability. The research also seeks to identify specific cognitive symptom profiles associated with fraud experiences among older adults.
Why it matters
Potential benefit: If successful, this research could lead to better protective measures against financial exploitation for older adults, particularly those with cognitive impairments.
How similar studies have gone: While there has been some research on cognitive decline and financial exploitation, this specific approach focusing on neurobiological mechanisms in ADRD patients is relatively novel.
Where this research is happening
-
University of Southern California
Los Angeles, United States Active
Researchers
- Principal investigator: Han, Duke — University of Southern California
- Study coordinator: Han, Duke
Related research
Other NIH-funded projects on the same topics.
-
Understanding how brain activity changes may drive Alzheimer’s disease progression in a mouse model
Researchers are testing how changes in brain signals and protein cleanup processes affect the development of Alzheimer’s disease in mice.
-
Thiamine-boosting therapy for Alzheimer’s: understanding how benfotiamine may reduce harmful AGE in DP patients
A medication-based approach using high-dose vitamin B1 (benfotiamine) is studied to help people with Alzheimer's by reducing harmful sugar-related molecules.
-
Non-invasive tears biomarker for early Alzheimer's in LMICs
A low-cost, tear-based biomarker approach aims to detect early Alzheimer’s disease in older adults in Peru and similar settings.
-
Turning APOE4 into protective APOE2 or APOE3Christchurch to help with Alzheimer’s
A patient-facing explanation of a treatment idea that aims to change a genetic risk factor for Alzheimer's disease in the brain.
-
Telomerase in Alzheimer’s Disease: how aging biology could influence memory and brain health
Researchers are exploring a new brain-aging mechanism linked to telomerase, with potential to slow or modify Alzheimer’s disease in people and improve cognitive function.
-
Biomarkers of Alzheimer’s Disease: Sensory, Motor, and Cognitive Clues
Researchers are testing simple sensory and movement tasks to find early signs of Alzheimer’s disease so they can diagnose and treat people sooner.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.